Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Prevention of COVID-19: Natural Products and Herbal Medicine
Junqing Huang, Gabriel Tao, Jingwen Liu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 175
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection
Lisa Henß, Arne Auste, Christoph Schürmann, et al.
Journal of General Virology (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 115
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
Ashuai Du, Rong Zheng, Cyrollah Disoma, et al.
International Journal of Biological Macromolecules (2021) Vol. 176, pp. 1-12
Open Access | Times Cited: 106
Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions
Safaet Alam, Md. Moklesur Rahman Sarker, Sadia Afrin, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 104
Medicinal Plants in COVID-19: Potential and Limitations
Xin Yi Lim, Bee Ping Teh, Terence Yew Chin Tan
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 88
Research progress of traditional Chinese medicine against COVID-19
Wei Ren, Pan Liang, Yue Ma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111310-111310
Open Access | Times Cited: 69
Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion
Tai Young Kim, Sangeun Jeon, Youngho Jang, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 5, pp. 956-972
Open Access | Times Cited: 67
A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery
Aekkhaluck Intharuksa, Warunya Arunotayanun, Wipawadee Yooin, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4479-4479
Open Access | Times Cited: 65
Herbal Remedies, Nutraceuticals, and Dietary Supplements for COVID-19 Management: An Update
Vivek P. Chavda, Aayushi Patel, Disha R. Vihol, et al.
Clinical Complementary Medicine and Pharmacology (2022) Vol. 2, Iss. 1, pp. 100021-100021
Open Access | Times Cited: 62
COVID-19 Prophylaxis Efforts Based on Natural Antiviral Plant Extracts and Their Compounds
Oksana Sytar, Marián Brestič, Shokoofeh Hajihashemi, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 727-727
Open Access | Times Cited: 61
Use of complementary and alternative medicine in general population during COVID-19 outbreak: A survey in Iran
Mahlagha Dehghan, Ali Ghanbari, Fatemeh Heidari, et al.
Journal of Integrative Medicine (2021) Vol. 20, Iss. 1, pp. 45-51
Open Access | Times Cited: 59
In silico evaluation of food‐derived carotenoids against SARS‐CoV ‐2 drug targets: Crocin is a promising dietary supplement candidate for COVID ‐19
Somdutt Mujwar, Lei Sun, Özkan Fidan
Journal of Food Biochemistry (2022) Vol. 46, Iss. 9
Open Access | Times Cited: 37
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Natural products and phytochemicals as potential anti‐SARS‐CoV‐2 drugs
Myriam Mérarchi, Namrata Dudha, Bhudev C. Das, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 10, pp. 5384-5396
Open Access | Times Cited: 49
Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets
Rittibet Yapasert, Patompong Khaw-on, Ratana Banjerdpongchai
Molecules (2021) Vol. 26, Iss. 24, pp. 7459-7459
Open Access | Times Cited: 49
Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling
Mohammad M. Al‐Sanea, Narek Abelyan, Mohamed A. Abdelgawad, et al.
Antibiotics (2021) Vol. 10, Iss. 7, pp. 824-824
Open Access | Times Cited: 45
The Use of Artificial Intelligence in Complementary and Alternative Medicine: A Systematic Scoping Review
Hongmin Chu, Seunghwan Moon, Jeongsu Park, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand
Karim Farmanpour-Kalalagh, Arman Beyraghdar Kashkooli, Alireza Babaei, et al.
Frontiers in Plant Science (2022) Vol. 13
Open Access | Times Cited: 30
In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
Md. Mominur Rahman, Md. Rezaul Islam, Shopnil Akash, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 29
Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials
Fatma A. Moharram, Reham R. Ibrahim, Shahenda Mahgoub, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313616-e0313616
Open Access
Prevention and Control of Acute Respiratory Viral Infections in Adult Population: A Systematic Review and Meta-Analysis on Ginseng-Based Clinical Trials
Frank Adusei‐Mensah, Richard Osei Agjei, Luqman O. Awoniyi, et al.
Deleted Journal (2025), pp. 200200-200200
Open Access
Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
Fatih M. Uckun, Saran Saund, Hitesh Windlass, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 39
Could Nanotechnology Help to End the Fight Against COVID-19? Review of Current Findings, Challenges and Future Perspectives
Ashagrachew Tewabe Yayehrad, Ebrahim Abdela Siraj, Gebremariam Birhanu Wondie, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 5713-5743
Open Access | Times Cited: 36
Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery
Zhonglei Wang, Liyan Yang, Xian‐En Zhao
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4684-4701
Open Access | Times Cited: 36
Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis
Von Novi O. de Leon, Joe Anthony Manzano, Delfin Yñigo H. Pilapil, et al.
Journal of Genetic Engineering and Biotechnology (2021) Vol. 19, Iss. 1, pp. 104-104
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top